TETEC AG

With more than 20 years of experience and expertise, TETEC AG is the European market leader in cartilage cell therapy, ATMPs (advanced therapy medicinal products) and suitable biomaterials... In 2003, TETEC GmbH was converted into an AG: we are part of the global B. Braun Group, our main shareholder is Aesculap AG. Headquartered in Reutlingen, TETEC AG operates as a subsidiary in the global B. Braun Group and therefore has a worldwide network. The development and manufacture of regenerative therapies are at the core of our company... But TETEC's mission does not end with our products: with our CDMO services, we want to share our expertise, experience and know-how and grow at the same time. As your expert partner, we will support you in the development and manufacture of ATMPs - from idea through all the clinical phases all the way to the commercialisation of your finished product.

Also known as: TETEC, TETEC GmbH

VAT numbers: DE 213156907

Primary location: Reutlingen Chile